| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.7B | $4.2B | $4.3B | $4.2B | $3.4B | $2.8B | $2.9B | $3.1B |
| Cost of Revenue | — | — | $1.5B | $1.7B | $1.0B | $0.7B | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $1.6B | $1.4B | $1.1B | $0.9B | $0.9B | $0.1B | $0.1B | $0.1B |
| Net Income | $1.2B | $1.0B | $0.9B | $0.8B | $0.7B | $0.1B | $0.1B | $0.0B |
| EPS (Basic) | $7.54 | $6.83 | $6.10 | $5.61 | $5.12 | $0.53 | $0.49 | — |
| EPS (Diluted) | $7.46 | $6.83 | $6.10 | $5.60 | $5.12 | $0.53 | $0.49 | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $28.2B | $25.2B | $22.5B | $22.2B | $19.6B | $15.4B | $13.4B | $11.9B |
| Current Assets | $1.1B | $1.1B | $0.9B | $3.0B | $2.8B | $0.5B | $0.5B | $0.5B |
| Cash & Equivalents | $0.2B | $0.3B | $0.0B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $1.4B | $1.2B | $1.4B | $3.6B | $3.5B | $0.8B | $1.2B | $1.9B |
| Stockholders' Equity | $13.6B | $12.2B | $10.9B | $9.4B | $7.9B | $6.8B | $5.8B | $4.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.0B | $1.7B | $3.5B | $1.0B | $-1.1B | $1.0B | $1.0B | $1.1B |
| Investing Cash Flow | $-3.6B | $-2.9B | $-2.8B | $-2.4B | $-2.0B | $-1.9B | $-1.7B | $-1.5B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $1.4B | $1.5B | $-0.7B | $1.4B | $3.1B | $0.9B | $0.7B | $0.3B |